The DPP4 Inhibitors Market represents a pivotal segment in the worldwide diabetes pharmaceutical industry, delivering substantial progress in type 2 diabetes care. These oral therapeutic agents operate by suppressing the dipeptidyl peptidase-4 enzyme, thereby enhancing the duration of incretin hormone activity that assists in maintaining blood glucose balance. As the global...